Product NDC: | 50458-192 |
Proprietary Name: | Ortho Evra |
Non Proprietary Name: | norelgestromin and ethinyl estradiol |
Active Ingredient(s): | .75; 6 mg/7d; mg/7d & nbsp; norelgestromin and ethinyl estradiol |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50458-192 |
Labeler Name: | Janssen Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021180 |
Marketing Category: | NDA |
Start Marketing Date: | 20011120 |
Package NDC: | 50458-192-24 |
Package Description: | 3 PATCH in 1 CARTON (50458-192-24) > 7 d in 1 PATCH |
NDC Code | 50458-192-24 |
Proprietary Name | Ortho Evra |
Package Description | 3 PATCH in 1 CARTON (50458-192-24) > 7 d in 1 PATCH |
Product NDC | 50458-192 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | norelgestromin and ethinyl estradiol |
Dosage Form Name | PATCH, EXTENDED RELEASE |
Route Name | TRANSDERMAL |
Start Marketing Date | 20011120 |
Marketing Category Name | NDA |
Labeler Name | Janssen Pharmaceutical, Inc. |
Substance Name | ETHINYL ESTRADIOL; NORELGESTROMIN |
Strength Number | .75; 6 |
Strength Unit | mg/7d; mg/7d |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |